MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors

Who May Qualify: - Primary ICH Diagnosis - Age ≥ 18 years - Discharge Modified Rankin Scale of ≤4 Who Should NOT Join This Trial: - Expected life expectancy of \<1 year - Patient or caregiver does not have access to WeRISE App. - Patient or caregiver does not know how to use WeRISE App . - Inability to perform home BP monitoring - Inability to participate in follow-up activity - Contraindication for intensive and rapid lowering of blood pressure (Known \>70% cerebral vascular stenosis; History of fall, dizziness or syncope due to hypotension; Any other medical condition that is deemed contraindicated for low blood pressure - Bleeding tendency (Platelet count \< 75 x 10\^9/L; Known coagulation disorder) - Severe renal impairment (Estimated glomerular filtration rate using CKD-EPI formula \<30 ml/min/1.73m2) - Severe liver impairment (Child-Pugh C cirrhosis) - Known contraindication or allergy to two or more anti-hypertensive classes Always talk to your doctor about whether this trial is right for you.